$APHB Strong Bullish Volume and Price Action.

On the top of our watchlist for the next week, speculation is rife about merger next week. Trade setup as per the chart.

AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa.